GC-1sobetirome side effects The dominant search intent for "gc-1 peptide" is to understand what this compound is, its properties, and its potential applications, particularly in relation to thyroid hormone receptors and metabolic effects. Many results point to it being a research chemical rather than a commonly available peptide.
Tier 1:
* Entities: GC-1, Sobetirome, Thyroid Hormone Receptor (TR), TRβ
* High-Relevance Phrases: thyromimetic drug, selective agonist, metabolic rate, obesity, fat mass, cholesterol lowering
Tier 2:
* Entities: TRα, TRβ1, TRβ2, rodents, rats, liver disorders, bile acid metabolism, lipid metabolism, hypothyroid rats
* Attributes/Variations: selective signaling, high affinity, EC50, KD values, metabolic syndrome, dyslipidemia, steatosis, hepatocyte proliferation, Ucp1 mRNA, D2 activity, adrenergic, tachycardia, reproductive performance, lactational performance
* Related Concepts: thyroid hormones, white fat, brown fat, collagen peptide, GLP-1
Tier 3:
* Entities: QRX431, KB2115, eprotirome, QRX-431, BLP-NT122, SLC25A22 (GC1)
* Commercial/Awkward Phrases: peptide for sale, bodybuilding, reddit, dosage, side effects, results, peptide program, Biolab Shop, AdooQ, Enzo, Tocris Bioscience, R&D Systems, Axon 4126, Rousselot, Peptan, NextidaGC, Global Labs, GC, 1, a, Gc, Peptides, peptides, peptide, GC1, peptide, GC 1, peptide, PeptideCoupling Reagents, Amino Acids, Protein Kinase Inhibitor, Cyclin-Dependent Kinase Inhibitor, FormylPeptideReceptor, Melanocortin Receptor, GRK, G Protein, Platelet, CAS 211110-63-3, Other Nuclear Receptors, Nuclear Receptor Agonists, GC 1 (4554)
---
GC-1, also widely known as Sobetirome, is a synthetically developed thyromimetic compound that acts as a selective agonist for thyroid hormone receptors (TRs), particularly the TRβ subtype. This selectivity is crucial, as thyroid hormones play a vital role in regulating metabolism, growth, and development. By mimicking the action of thyroid hormones but with a preferential affinity for TRβ, GC-1 offers a targeted approach to influencing metabolic processes without eliciting the broader, potentially undesirable side effects associated with endogenous thyroid hormones.Sobetirome - Wikipedia Research has highlighted its potential in addressing conditions like obesity and metabolic syndrome by influencing fat mass and cholesterol levels.Sobetirome - an overview | ScienceDirect Topics
The primary function of GC-1 is to bind to and activate thyroid hormone receptors, specifically TRβ1 and TRβ2, with a higher affinity than TRα receptors. This selective binding is key to its therapeutic potential. Thyroid hormone receptors are nuclear receptors that, upon activation by thyroid hormones or their mimetics like GC-1, regulate gene expression.Thyroid Hormone Receptor激动剂、基因 This regulation impacts a wide array of physiological functions, including energy expenditure, lipid metabolism, and cardiovascular function. GC-1's preference for TRβ allows it to modulate these pathways in a more targeted manner. Studies have shown that GC-1 can increase metabolic rate, leading to a reduction in fat mass without significantly affecting lean mass or heart rate, a common concern with less selective thyromimetics.Selective activation of thyroid hormone signaling pathways ...
The most extensively studied application of GC-1 lies in its potential to combat metabolic disorders.GC 1 | Nuclear Receptor Agonists: Tocris Bioscience - R&D Systems Its ability to increase metabolic rate and promote the conversion of white fat (which stores calories) into brown fat (which burns calories) makes it a promising candidate for weight management. Research in rodents has demonstrated that GC-1 can effectively reduce accumulated fat, prevent steatosis (fatty liver), and lower cholesterol levels. These effects are attributed to its influence on lipid and bile acid metabolism, as well as its ability to induce hepatocyte proliferation. By selectively activating TRβ, GC-1 may offer a therapeutic avenue for individuals suffering from obesity, dyslipidemia, and the broader metabolic syndrome, potentially improving cardiovascular health markers as well.
GC-1 serves as a valuable research tool for scientists investigating the complex roles of thyroid hormone signaling pathways. Its selectivity allows for precise studies into the specific functions of TRβ in various tissues and physiological processes. Beyond metabolic research, GC-1 has been explored for its effects on liver disorders, suggesting a broader therapeutic scope. While its primary applications are still within the research domain, the ongoing investigation into its synthesis and biological effects continues to pave the way for potential clinical applications. The development of improved synthesis strategies for GC-1 aims to make this compound more accessible for further study and potential therapeutic development.
It is important to distinguish GC-1 (Sobetirome) from other compounds that may share similar nomenclature or general function. While the term "peptide" is sometimes associated with GC-1 due to its use in biochemical research and the presence of related terms in search queries, GC-1 itself is a synthetic small molecule, not a peptide in the traditional sense. Other peptides, such as collagen peptides, are unrelated and serve entirely different biological functions. Furthermore, GC-1's specific affinity for TRβ distinguishes it from less selective thyroid hormone receptor agonists or endogenous thyroid hormones, which interact with both TRα and TRβ receptors, potentially leading to a wider range of physiological effects.Sobetirome - Enzo
In conclusion, GC-1 (Sobetirome) represents a significant advancement in the study of thyroid hormone mimetics. Its selective action on TRβ receptors offers a targeted approach to modulating metabolism, with promising implications for treating obesity, metabolic syndrome, and related conditions. While still largely a subject of preclinical research, its unique biochemical profile and demonstrated effects on fat mass and cholesterol metabolism position it as a compound of considerable scientific interestProtein Kinase InhibitorPeptide(PKI) · Cyclin-Dependent Kinase Inhibitor ... Sobetirome (GC-1) 是一种甲状腺激素受体β (TRβ) 激动剂，Sobetirome 可选择性 ....
Join the newsletter to receive news, updates, new products and freebies in your inbox.